trending Market Intelligence /marketintelligence/en/news-insights/trending/lysahrmyaovya17xgcvcra2 content esgSubNav
In This List

Cancer Genetics chief medical officer leaves to pursue other research interests

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


Cancer Genetics chief medical officer leaves to pursue other research interests

Cancer Genetics Inc. said Rita Shaknovich will resign as chief medical officer and group medical director effective Sept. 12.

The Rutherford, N.J.-based company believes its existing staff will be able to manage ongoing operations and is exploring internal promotions to ensure a smooth transition of Shaknovich's responsibilities.

Shaknovich plans to pursue other interests related to oncology research, the company said in an Aug. 10 regulatory filing.